These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30914657)

  • 1. Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6.
    Chryplewicz A; Tienda SM; Nahotko DA; Peters PN; Lengyel E; Eckert MA
    Sci Rep; 2019 Mar; 9(1):5195. PubMed ID: 30914657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant p53 expression in fallopian tube epithelium drives cell migration.
    Quartuccio SM; Karthikeyan S; Eddie SL; Lantvit DD; Ó hAinmhire E; Modi DA; Wei JJ; Burdette JE
    Int J Cancer; 2015 Oct; 137(7):1528-38. PubMed ID: 25810107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 loss initiates chromosomal instability in fallopian tube epithelial cells.
    Bronder D; Tighe A; Wangsa D; Zong D; Meyer TJ; Wardenaar R; Minshall P; Hirsch D; Heselmeyer-Haddad K; Nelson L; Spierings D; McGrail JC; Cam M; Nussenzweig A; Foijer F; Ried T; Taylor SS
    Dis Model Mech; 2021 Nov; 14(11):. PubMed ID: 34569598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma.
    Ghannam-Shahbari D; Jacob E; Kakun RR; Wasserman T; Korsensky L; Sternfeld O; Kagan J; Bublik DR; Aviel-Ronen S; Levanon K; Sabo E; Larisch S; Oren M; Hershkovitz D; Perets R
    Oncogene; 2018 Apr; 37(17):2213-2224. PubMed ID: 29379162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
    [No Abstract]   [Full Text] [Related]  

  • 6. Progesterone Prevents High-Grade Serous Ovarian Cancer by Inducing Necroptosis of p53-Defective Fallopian Tube Epithelial Cells.
    Wu NY; Huang HS; Chao TH; Chou HM; Fang C; Qin CZ; Lin CY; Chu TY; Zhou HH
    Cell Rep; 2017 Mar; 18(11):2557-2565. PubMed ID: 28297660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cadherin-6 type 2, K-cadherin (CDH6) is regulated by mutant p53 in the fallopian tube but is not expressed in the ovarian surface.
    Karthikeyan S; Lantvit DD; Chae DH; Burdette JE
    Oncotarget; 2016 Oct; 7(43):69871-69882. PubMed ID: 27563818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A gonadotropin-releasing hormone-responsive phosphatase hydrolyses lysophosphatidic acid within the plasma membrane of ovarian cancer cells.
    Imai A; Furui T; Tamaya T; Mills GB
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3370-5. PubMed ID: 10999836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling high-grade serous ovarian carcinogenesis from the fallopian tube.
    Karst AM; Levanon K; Drapkin R
    Proc Natl Acad Sci U S A; 2011 May; 108(18):7547-52. PubMed ID: 21502498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCNG1 (Cyclin G1) regulation by mutant-P53 via induction of Notch3 expression promotes high-grade serous ovarian cancer (HGSOC) tumorigenesis and progression.
    Xu Y; Zhang Q; Miao C; Dongol S; Li Y; Jin C; Dong R; Li Y; Yang X; Kong B
    Cancer Med; 2019 Jan; 8(1):351-362. PubMed ID: 30565428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas.
    Soong TR; Howitt BE; Miron A; Horowitz NS; Campbell F; Feltmate CM; Muto MG; Berkowitz RS; Nucci MR; Xian W; Crum CP
    J Pathol; 2018 Nov; 246(3):344-351. PubMed ID: 30043522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1.
    Tanaka N; Zhao M; Tang L; Patel AA; Xi Q; Van HT; Takahashi H; Osman AA; Zhang J; Wang J; Myers JN; Zhou G
    Oncogene; 2018 Mar; 37(10):1279-1292. PubMed ID: 29269868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of ACP6 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
    Ando T; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Kurehara H; Sugito N; Tomoda K; Mori R; Takashima N; Ogawa R; Fujii Y
    Oncol Rep; 2006 Jun; 15(6):1551-5. PubMed ID: 16685394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic acid stimulates cell migration, invasion, and colony formation as well as tumorigenesis/metastasis of mouse ovarian cancer in immunocompetent mice.
    Li H; Wang D; Zhang H; Kirmani K; Zhao Z; Steinmetz R; Xu Y
    Mol Cancer Ther; 2009 Jun; 8(6):1692-701. PubMed ID: 19509252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic acid phosphatase degrades lysophosphatidic acid in seminal plasma.
    Tanaka M; Kishi Y; Takanezawa Y; Kakehi Y; Aoki J; Arai H
    FEBS Lett; 2004 Jul; 571(1-3):197-204. PubMed ID: 15280042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.
    Tigyi GJ; Yue J; Norman DD; Szabo E; Balogh A; Balazs L; Zhao G; Lee SC
    Adv Biol Regul; 2019 Jan; 71():183-193. PubMed ID: 30243984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of the p53-dependent replicative senescence response by lysophosphatidic acid signaling.
    Kortlever RM; Brummelkamp TR; van Meeteren LA; Moolenaar WH; Bernards R
    Mol Cancer Res; 2008 Sep; 6(9):1452-60. PubMed ID: 18723828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer.
    Modi DA; Tagare RD; Karthikeyan S; Russo A; Dean M; Davis DA; Lantvit DD; Burdette JE
    Oncogene; 2017 May; 36(21):3015-3024. PubMed ID: 27991925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYC is sufficient to generate mid-life high-grade serous ovarian and uterine serous carcinomas in a p53-R270H mouse model.
    Blackman A; Rees AC; Bowers RR; Jones CM; Vaena SG; Clark MA; Carter S; Villamor ED; Evans D; Emanuel AJ; Fullbright G; Long DT; Spruill L; Romeo MJ; Helke KL; Delaney JR
    bioRxiv; 2024 Jan; ():. PubMed ID: 38352443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures and biochemical studies of human lysophosphatidic acid phosphatase type 6.
    Li J; Dong Y; Lü X; Wang L; Peng W; Zhang XC; Rao Z
    Protein Cell; 2013 Jul; 4(7):548-61. PubMed ID: 23807634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.